Acknowledgements |
|
x | |
|
|
1 | (72) |
|
1 Managing integrity in sport: the case of drug control |
|
|
3 | (15) |
|
Managing drugs and integrity: corporate social responsibility |
|
|
4 | (7) |
|
|
11 | (2) |
|
How sport manages drugs in sport - structure of the book |
|
|
13 | (5) |
|
2 The role of drugs in sport |
|
|
18 | (16) |
|
Defining the first dimension: drugs |
|
|
18 | (1) |
|
Defining the second dimension: use, misuse and abuse |
|
|
19 | (2) |
|
|
21 | (1) |
|
|
21 | (8) |
|
Implications of the sports drug matrix for managing drugs in sport |
|
|
29 | (5) |
|
3 The evolution of drug control for sport |
|
|
34 | (21) |
|
From ancient times to the Renaissance |
|
|
34 | (1) |
|
Pre-industrial drug control |
|
|
35 | (1) |
|
The emergence of modern sport |
|
|
36 | (1) |
|
|
37 | (1) |
|
The emergence of drug control for sport |
|
|
38 | (1) |
|
Post-war drug control: the war on drugs |
|
|
39 | (1) |
|
The war on drugs in sport begins |
|
|
40 | (4) |
|
Tobacco sponsorship: sport continues to lose the initiative |
|
|
44 | (1) |
|
Lost initiative: drug scandals and reactionary crisis management |
|
|
45 | (1) |
|
Regaining the initiative: the rise of anti-doping |
|
|
46 | (2) |
|
|
48 | (1) |
|
Potentially losing the initiative in the future |
|
|
49 | (1) |
|
|
50 | (1) |
|
|
50 | (5) |
|
4 Policy context for managing drugs in sport |
|
|
55 | (18) |
|
|
55 | (3) |
|
Critiques of the anti-doping policy |
|
|
58 | (4) |
|
Status of the anti-doping policy |
|
|
62 | (1) |
|
Alternatives to the anti-doping policy |
|
|
63 | (6) |
|
Drug control policy alternatives for sport |
|
|
69 | (4) |
|
|
73 | (100) |
|
5 Drug control and the business of sport |
|
|
75 | (14) |
|
Structure of the sports industry |
|
|
75 | (5) |
|
|
80 | (2) |
|
|
82 | (4) |
|
The business of managing drugs in sport |
|
|
86 | (3) |
|
6 Business ethics and drug control for sport |
|
|
89 | (19) |
|
Virtues and the Spirit of Sport |
|
|
90 | (4) |
|
A different virtues approach to drug control for sport |
|
|
94 | (5) |
|
Virtues and drug control for sport |
|
|
99 | (1) |
|
Extending the debate to other ethical perspectives |
|
|
99 | (4) |
|
Kick starting the business ethics of drug control for sport |
|
|
103 | (5) |
|
7 Governance of drugs in sport |
|
|
108 | (17) |
|
Systemic governance of anti-doping |
|
|
109 | (6) |
|
Organisational governance of anti-doping |
|
|
115 | (6) |
|
The good and bad of governance for drugs in sport |
|
|
121 | (4) |
|
8 Managing drug risks in sport |
|
|
125 | (14) |
|
|
125 | (6) |
|
Managing risks from doping and anti-doping |
|
|
131 | (4) |
|
Managing the integrity risks of drugs in sport |
|
|
135 | (4) |
|
9 Human resources and drugs in sport |
|
|
139 | (18) |
|
Front line HRM responses to drugs in sport |
|
|
139 | (4) |
|
CSR, strategic HRM and drugs in sport |
|
|
143 | (9) |
|
Linking CSR and the HRM of drugs in sport |
|
|
152 | (5) |
|
10 Marketing, integrity management and drugs in sport |
|
|
|
Co-Authored With Daniel Prior |
|
|
157 | (1) |
|
Marketing of licit drugs in sport |
|
|
158 | (4) |
|
|
162 | (3) |
|
|
165 | (3) |
|
Marketing drugs and integrity in sport |
|
|
168 | (5) |
|
PART III Drug control-led integrity management |
|
|
173 | (43) |
|
11 Managing drugs beyond elite male sport |
|
|
175 | (20) |
|
Managing drugs in women's sport |
|
|
175 | (4) |
|
Managing drugs in children's sport |
|
|
179 | (5) |
|
Managing drugs in non-elite sport |
|
|
184 | (4) |
|
Drug control for all sport |
|
|
188 | (7) |
|
12 Second generation drug control for sport |
|
|
195 | (14) |
|
|
195 | (1) |
|
Implementation of harm-minimisation |
|
|
196 | (6) |
|
Harm-minimisation and the challenges of anti-doping |
|
|
202 | (1) |
|
Potential wicked problems for harm-minimisation |
|
|
203 | (3) |
|
Second generation drug control for sport and sports integrity |
|
|
206 | (3) |
|
13 Reflections on sport, drugs and integrity management |
|
|
209 | (7) |
|
|
209 | (3) |
|
|
212 | (2) |
|
Personal reflections on sports, drugs and integrity |
|
|
214 | (2) |
Conclusions on drugs, sport and integrity |
|
216 | (1) |
Index |
|
217 | |